News Quantified

ETNB – 89bio, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

89bio to Host Key Opinion Leader Webinar on Pegozafermin's Opportunity in Advanced MASH [Yahoo! Finance]

89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH

89bio, Inc. (NASDAQ: ETNB) had its "buy" rating re-affirmed by analysts at Bank of America Co.. They now have a $30.00 price target on the stock.

89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors [Yahoo! Finance]

89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors

-4.9%

BEAT

3.3%

MISS

Cantor Fitzgerald

Cantor Fitzgerald

Evercore ISI Group

Form 4 89bio, Inc. For: May 02 Filed by: Babler Martin

Form 3 89bio, Inc. For: Apr 13 Filed by: Babler Martin

Form ARS 89bio, Inc. For: Dec 31

Form DEFA14A 89bio, Inc.

Form DEF 14A 89bio, Inc. For: May 29

Top News Gainers

11/15 Form 8-K 89bio, Inc. For: Nov 13 16.7%

3/18 Q4/2019 12/31/2019 EPS 2.580 ZacksConsensus -0.810 ActVsEst 3.390 - Beat 13.1%

11/13 Form 4 89bio, Inc. For: Nov 11 Filed by: Kolchinsky Peter 12.9%

4/23 Form 8-K 89bio, Inc. For: Apr 17 10.9%

11/25 Form SC 13G 89bio, Inc. Filed by: Venrock Healthcare Capital Partners II, L.P. 9.0%

2/21 89bio to Present at the SVB Leerink 9th Annual Global Healthcare Conference 7.7%

3/26 Form 8-K 89bio, Inc. For: Mar 23 7.6%

2/14 Form SC 13G 89bio, Inc. Filed by: Nussbaum Ran 5.5%

11/8 Form S-1MEF 89bio, Inc. 4.0%

11/12 Form 424B4 89bio, Inc. 3.8%

Top News Decliners

12/18 Form 10-Q 89bio, Inc. For: Sep 30 -14.9%

4/29 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $28.00 price target on the stock. -9.5%

12/9 89bio (NASDAQ: ETNB) is now covered by analysts at Bank of America Corp. They set a "neutral" rating on the stock. -7.7%

11/12 89Bio debuts IPO [Reuters] -5.0%

12/31 Form 8-K 89bio, Inc. For: Dec 24 -4.5%

4/7 89bio (NASDAQ: ETNB) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $24.00 price target on the stock. -4.2%

4/23 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -3.8%

2/19 Form 4 89bio, Inc. For: Feb 14 Filed by: PALEKAR ROHAN -3.7%

11/21 Form SC 13D 89bio, Inc. Filed by: Longitude Capital Partners III, LLC -2.3%

4/7 89bio (NASDAQ: ETNB) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -2.1%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day